Related Experiment Video
Updated: Mar 31, 2026
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
Virus-mimetic nanovesicles as a versatile antigen-delivery system.
Pengfei Zhang1, Yixin Chen2, Yun Zeng3
1State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics and Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, China;
Developing novel vaccines is crucial for pandemic preparedness. This study introduces virus-mimetic nanovesicles (VMVs) that display viral antigens, offering a promising platform for rapid vaccine development against enveloped viruses.
Area of Science:
- Biotechnology
- Virology
- Vaccine Development
Background:
- Rapid vaccine design is critical for managing pandemics.
- Enveloped viruses utilize host cell membranes for replication and release.
- Existing vaccine platforms may face challenges in speed and efficacy.
Purpose of the Study:
- To engineer a novel nanobiotechnology platform for rapid vaccine development.
- To create virus-mimetic nanovesicles (VMVs) displaying native viral antigens.
- To establish VMVs as a versatile system for antigen delivery against enveloped viruses.
Main Methods:
- Genetically engineering viral antigens into host cell membranes.
- Utilizing surfactants to generate uniform, spherical virus-mimetic nanovesicles (VMVs).
- Characterizing VMVs for size, shape, and display of conformational epitopes.
Main Results:
- Successfully generated nano-sized VMVs resembling natural viruses in key characteristics.
- VMVs effectively displayed native conformational epitopes and viral envelope glycoproteins.
- Demonstrated the robustness and tunability of VMVs for antigen delivery.
Conclusions:
- Virus-mimetic nanovesicles (VMVs) represent a straightforward and adaptable platform for vaccine fabrication.
- VMVs show significant potential for developing rapid and effective vaccines against diverse enveloped viruses.
- This nanobiotechnology approach offers a promising strategy for future pandemic preparedness.
